Other substances

FlowVax COVID-19

COVID-19 candidate vaccine

Phase of research

Potential treatment - theoretical effect

How it helps

Vaccine

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

FlowVax COVID-19 is a candidate vaccine being developed by Flow Pharma Inc. It is a peptide type of candidate vaccine, based on the Protein Subunit platform. Currently, this COVID-19 candidate vaccine is in pre-clinical evaluation.

FlowVax COVID-19

 

Supporting references

Link Tested on Impact factor Notes Publication date
DRAFT landscape of COVID-19 candidate vaccines – 26 March 2020
in vitro Mar/26/2020
Export (.csv)